The Drug Development Fellowship is aimed at Medical Doctors who are currently undergoing specialist training (StR/SpR) in Oncology.
Established in 2013, the program was designed to diversify and broaden clinical training through exposure to clinical research methodology from the pharmaceutical medicine perspective. The fellowship will be 1 year in duration, primarily based at Roche Products Ltd in Welwyn Garden City, UK, within the Clinical Development Group; responsible for the strategy, design and execution of early phase clinical trials.
There will be the opportunity for travel and direct interaction across Roche/Genentech. Your supervisor will be an experienced, UK accredited Consultant Physician Based in Roche, Welwyn working within Clinical Development. In order to take up the post, you will be expected to have an Out Of Program (OOP) approved by your Training Programme Director/Deanery.
As a Fellow in the Global Clinical Development Group you may:
Be involved in the design, execution, analysis and interpretation of data from clinical studies for molecules early in development as well as marketed compounds.
Interact with globally recognized academic experts and clinical investigators
Participate in key clinical strategy, implementation and molecule management meetings in order to gain a deeper understanding of the complexities and challenges of medicines development
Provide clinical expertise in the Oncology disease areas for cross functional pharmaceutical development teams
Generate and present abstracts and oral presentations for key external conferences (e.g., EHA, ASH, ASCO, ICML) and other specialty meetings as well as publication opportunities.
Be involved in discussions and initiatives around Personalized Health Care (PHC) and patient selection for different therapeutic interventions
Who is the Roche Clinical Research Fellowship suitable for?
An ST3+ Oncology Medical Doctor trainee looking to diversify their training. While some previous clinical research experience is preferred, it is not essential.
A trainee interested in further understanding and influencing the development and approval of medicines for patients with blood and solid cancers. Note: this is not intended to be a basic science fellowship leading to a post graduate degree, although the clinical research could supplement or inform existing basic research if appropriate.
Why a Pharmaceutical Industry Fellowship?
Collaborations between pharmaceutical companies, the health service and academia are key to improving patient outcomes and care
Understanding drug development, regulation and the reimbursement process is critical for physicians wishing to influence the delivery of healthcare
Our fellowships offer a unique insight training for those wishing to participate or conduct clinical trials in their future careers
Abundant scope for research opportunities using large impactful datasets and the chance to work with key opinion leaders
Over many years Roche has generated a wealth of clinical databases from clinical trials and patient registries. Trainees will benefit from access to these resources around which projects can be designed and carried out with the support of skilled biostatisticians.
Previous fellows have thoroughly enjoyed their experience, gained valuable knowledge and contacts and opportunities to further their careers
Times Top 100 Best Companies to Work for 2019
Phase 1: CV & Cover Letter screen
Phase 2: Interview & Presentation
Please ensure you include a CV and cover letter with your initial application (DO NOT USE QUICK APPLY OPTION) any application without a cover letter is automatically declined. As part of your cover letter, Roche is keen to understand your motivation in applying for this position. You should, therefore, provide responses to the following:
- Your key motivation for applying to this placement
- What key skills and experience will you bring to the role
- What personal qualities will you bring to the role
Your cover letter should not exceed one page.
Roche is an equal opportunity employer.Research & Development, Research & Development > Clinical Development